Venaseal
Device EndoVenous Therapies
PDI 10884521539921
General payments
$2,524,340
Research payments
$1,694,883
Through program year 2025, $2,524,340 in general payments and $1,694,883 in research payments were reported against Venaseal (EndoVenous Therapies).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $519,334 | 5,976 |
| 2025 | Research | $279,338 | 62 |
| 2024 | General | $754,937 | 5,873 |
| 2024 | Research | $259,340 | 47 |
| 2023 | General | $587,281 | 6,167 |
| 2023 | Research | $461,657 | 63 |
| 2022 | General | $662,788 | 5,790 |
| 2022 | Research | $694,548 | 75 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 85 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
23,806 general · 247 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.